Skip to content
TirzepatideReport

Tracked provider

Mevo Health tirzepatide review

Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu.

This is a tracked entry: the facts below are what Mevo Health publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-07-25). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on Mevo Health's own site before you pay.

What it costs

Tirzepatide
$259/mo (all doses, compounded)
What is dispensed
Compounded tirzepatide
Who compounds it
Unspecified

How the program works

An online intake is reviewed by a licensed clinician. Publishes its price before you start the intake.

What we like

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

The caveats

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed

Ready to look at Mevo Health directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit Mevo Health

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review